Victoria Cornelius is Director of Imperial Clinical Trials Unit (ICTU) and holds a Chair in Medical Statistics and Trial Methodology at Imperial College London. Her research in trials includes evaluating drug and complex interventions developing approaches that promote statistical efficiency in both Bayesian and frequentist frameworks. Victoria is dedicated to translating best statistical practice into applied research. She established the NIHR Statistics Group in 2011 with support from NOCRI, and the ICTU Trial Methodology Group in 2019. She currently co-leads an international specialist research group in NIHR MRC TMRP to improve the analysis of harm outcomes in randomised controlled trials and has led multiple national research initiatives to improve the use of statistical methods in laboratory studies, feasibility and early phase clinical trials.
Victoria has supervised both clinical and methodological NIHR fellows undertaking research in clinical Trials. Projects include examining the use of Digital Health Interventions (DHI) to improve mental health, Methods to elicit prior distributions for trials in uncommon conditions, and the analysis of adverse events. Victoria has been a member of several funding committees including NIHR EME, Joint Global Health Trials funding Committee, Wellcome Trust specialist call for trials research and is currently a member of the NIHR Academy Doctoral fellowship board.
After obtaining a BSc in Mathematics and competing a PhD in Statistics in 2000, Victoria joined the Centre for Statistics in Medicine in Oxford working on cancer studies. In 2005 she moved to the Drug Safety Research Unit working part-time designing and analysing post-marketing surveillance studies to monitor the safety of medicines newly released to market. In 2009 she moved to the NIHR Biomedical Research Unit (BRU) at Southampton University as a senior statistician working on allergy and respiratory translational research projects and became Senior Lecturer in Medical Statistics at King’s College London in 2011 and the Deputy Director for Research Design Service London. Victoria joined Imperial College London in February 2016 as Deputy Head of Statistics for ICTU and was promoted to Reader in Medical Statistics in 2019, and Head of Trial Methodology in 2020.
et al., 2023, A randomised controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalised with COVID-19: the C19-ACS trial, Journal of Thrombosis and Haemostasis, Vol:21, ISSN:1538-7836, Pages:2213-2222
et al., 2023, Expression of antenatal symptoms of common mental disorders in The Gambia and the UK: a cross-sectional comparison study., Bmj Open, Vol:13
et al., 2023, A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma – the ASCOT study, Health Technology Assessment, Vol:27, ISSN:1366-5278, Pages:1-50
et al., 2023, Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial, Journal of Infection, Vol:87, ISSN:0163-4453, Pages:18-26
et al., 2023, Pilot feasibility study of a digital technology approach to the systematic electronic capture of parent-reported data on cognitive and language development in children aged 2 years, Bmj Health & Care Informatics, Vol:30, ISSN:2632-1009, Pages:1-5